MK 5172 potassiuM salt
- Product NameMK 5172 potassiuM salt
- CAS1206524-86-8
- CBNumberCB02666660
- MFC38H49N6O9S.K
- MW807.02
- MDL NumberMFCD25976701
- MOL File1206524-86-8.mol
Chemical Properties
storage temp. | Store at -20°C |
solubility | DMSO:100.0(Max Conc. mg/mL);124.22(Max Conc. mM) |
form | Powder |
MK 5172 potassiuM salt Price
Product number | Packaging | Price | Product description | Buy |
---|---|---|---|---|
ChemScene CS-1375 | 5mg | $108 | Grazoprevirpotassiumsalt 99.40% |
Buy |
ApexBio Technology A3620 | 1mg | $126 | MK-5172potassiumsalt |
Buy |
ChemScene CS-1375 | 10mg | $168 | Grazoprevirpotassiumsalt 99.40% |
Buy |
ChemScene CS-1375 | 50mg | $540 | Grazoprevirpotassiumsalt 99.40% |
Buy |
ChemScene CS-1375 | 100mg | $780 | Grazoprevirpotassiumsalt 99.40% |
Buy |
MK 5172 potassiuM salt Chemical Properties,Usage,Production
Description
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development. IC50 Value: 7.4 nM and 7 nM for genotype 1b and 1a respectively, in replicon system [1] Target: HCV NS3/4a proteasein vitro
in vitro: In biochemical assays, MK-5172 was effective against a panel of major genotypes and variants engineered with common resistant mutations observed in clinical studies with other NS3/4a protease inhibitors. In the replicon assay, MK-5172 demonstrated subnanomolar to low-nanomolar EC50s against genotypes 1a, 1b, and 2a [2].in vivo
in vivo: In rats, MK-5172 showed a plasma clearance of 28 ml/min/kg and plasma half-life of 1.4 hr. When dosed p.o. at 5 mg/kg, the plasma exposure of MK-5172 was good with an AUC of 0.7 uM.hr. The liver exposure of the compound was quite good (23 uM at 4 hr), and MK-5172 remained in liver 24 hr after a single p.o. 5 mg/kg dose. At 24 hr, the liver concentration of MK-5172 was 0.2 uM, which was over 25-fold higher than the IC50 in the replicon assay with 50% NHS. When dosed to dogs, MK-5172 showed low clearance of 5 ml/min/kg and a 3 hr half-life after i.v. 2 mg/kg dosing and had good plasma exposure (AUC=0.4 uM.hr) after a p.o. 1 mg/kg dose [1]. Clinical trial: Evaluation of Hepatic Pharmacokinetics for MK-5172 in Participants With Chronic Hepatitis C . Phase1References
References:[1]. Steven Harper , John A. McCauley , Michael T. Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor. ACS Med. Chem. Lett., 2012, 3 (4), pp 332-336 [2]. Summa V, Ludmerer SW, McCauley JA, MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants. Antimicrob Agents Chemother. 2012 Aug;56(8):4161-7.Preparation Products And Raw materials
MK 5172 potassiuM salt Supplier
Global(33)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
+86-0371-86658258 | sales@coreychem.com | China | 29914 | 58 | |
+86-023-61398051 +8613650506873 |
sales@chemdad.com | China | 39916 | 58 | |
+1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 19892 | 58 | |
+1-708-310-1919 +1-13798911105 |
sales@invivochem.cn | United States | 6393 | 58 | |
+86-0576225566889 +86-13454675544 |
admin@jiuzhou-chem.com;jamie@jiuzhou-chem.com;alice@jiuzhou-chem.com | China | 20000 | 58 | |
+86-0371-88006763; +8615988602810 |
sales@anbuchem.com | China | 3000 | 58 | |
571-89925085 | sales@amadischem.com | China | 131981 | 58 | |
021-58950125 | info@chemexpress.com | China | 7553 | 61 | |
021-58955995 | sales@medchemexpress.cn | United States | 4863 | 58 | |
18149758185 | sales-cpd@caerulumpharma.com | China | 3421 | 58 |
1206524-86-8, MK 5172 potassiuM saltRelated Search
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China
The What'sApp is temporarily not supported in mainland China
Cancel
Determine